603882.SHG Guangzhou Kingmed Diagnostics Group Co Ltd
- Market cap
- CNY 13.3B
- P/E
- 46.5x
- P/B
- 1.98x
- ROE
- 7.7%
- Dividend yield
- 3.10%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603882.SHG undervalued?
Graham number603882.SHG trades 102.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Guangzhou Kingmed Diagnostics Group Co Ltd fundamental analysis
No fundamental analysis for Guangzhou Kingmed Diagnostics Group Co Ltd yet.
Guangzhou Kingmed Diagnostics Group Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logistics, and other services, as well as sells diagnostic products. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Full company profileGuangzhou Kingmed Diagnostics Group Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Guangzhou Kingmed Diagnostics Group Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.22B | 3.79B | 4.53B | 5.27B | 8.24B | 11.9B | 15.5B | 8.54B | 7.19B | 6.03B | 5.87B |
| Gross Profit | 1.36B | 1.55B | 1.76B | 2.08B | 3.85B | 5.65B | 6.67B | 3.12B | 2.38B | 2.10B | 2.16B |
| Operating Income | 189M | 263M | 312M | 484M | 1.82B | 2.78B | 3.35B | 760M | -273M | 242M | 505M |
| EBITDA | 345M | 422M | 529M | 694M | 2.07B | 3.06B | 3.68B | 867M | 258M | 248M | 664M |
| Net Income | 170M | 189M | 233M | 402M | 1.51B | 2.22B | 2.75B | 643M | -381M | -173M | 498M |
| EPS | 0.44 | 0.46 | 0.51 | 0.88 | 3.27 | 4.76 | 5.89 | 1.38 | -0.82 | -0.37 | 1.08 |
| Balance Sheet | |||||||||||
| Total Assets | 2.67B | 3.32B | 3.96B | 4.40B | 6.64B | 10.8B | 13.9B | 11.8B | 10.4B | 9.60B | 9.32B |
| Total Liabilities | 1.53B | 1.58B | 2.00B | 2.07B | 2.76B | 4.23B | 5.02B | 3.22B | 2.92B | 2.75B | 2.70B |
| Shareholders' Equity | 1.10B | 1.70B | 1.91B | 2.27B | 3.79B | 6.30B | 8.63B | 8.36B | 7.33B | 6.73B | 6.47B |
| Cash & Short-term Investments | 530M | 649M | 842M | 955M | 1.64B | 2.65B | 2.93B | 2.46B | 2.43B | 2.85B | 2.39B |
| Total Debt | 706M | 577M | 746M | 615M | 462M | 622M | 568M | 449M | 634M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 292M | 284M | 530M | 661M | 1.52B | 2.09B | 1.95B | 1.23B | 906M | 1.20B | - |
| Capital Expenditure | 430M | 380M | 346M | 275M | 551M | 952M | 841M | 715M | 446M | 423M | 444M |
| Free Cash Flow | -138M | -96.3M | 183M | 386M | 972M | 1.14B | 1.11B | 516M | 460M | 779M | 342M |
| Ratios | |||||||||||
| ROE | 15.5% | 11.1% | 12.2% | 17.7% | 39.9% | 35.2% | 31.9% | 7.7% | -5.2% | -2.6% | 7.7% |
| ROA | 6.4% | 5.7% | 5.9% | 9.2% | 22.7% | 20.6% | 19.8% | 5.5% | -3.7% | -1.8% | 5.3% |
| Net Profit Margin | 5.3% | 5.0% | 5.2% | 7.6% | 18.3% | 18.6% | 17.8% | 7.5% | -5.3% | -2.9% | 8.5% |
| Debt to Equity | 0.64x | 0.34x | 0.39x | 0.27x | 0.12x | 0.10x | 0.07x | 0.05x | 0.09x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Guangzhou Kingmed Diagnostics Group Co Ltd dividends
- Dividend yield
- 3.10%
- Forward dividend
- 0.88 CNY
- Payout ratio
- -
- Ex-dividend date
- Feb 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 414M | 0.89 | - |
| 2024 | CNY 420M | 0.90 | - |
| 2023 | CNY 839M | 1.80 | 130.5% |
| 2022 | CNY 596M | 1.28 | 21.6% |
| 2021 | CNY 152M | 0.33 | 6.9% |
| 2020 | CNY 62.3M | 0.13 | 4.1% |
| 2019 | CNY 49.5M | 0.11 | 12.3% |
| 2018 | CNY 40.5M | 0.09 | 17.3% |
| 2017 | CNY 35.2M | 0.09 | 18.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Guangzhou Kingmed Diagnostics Group Co Ltd
- Insiders 41.82%
- Institutions 10.29%
- Public & others 47.88%
- Shares outstanding 463M
- Free float 280M
Guangzhou Kingmed Diagnostics Group Co Ltd company profile
- Company name
- Guangzhou Kingmed Diagnostics Group Co Ltd
- Ticker
- 603882.SHG
- ISIN
- CNE100002VW1
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- Employees
- 9,529
- Fiscal year end
- December
- Address
- No. 10, Spiral Third Road, Guangzhou, China, 510000
- Phone
- 86 20 2919 6326
- Website
- kingmed.com.cn
About Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logistics, and other services, as well as sells diagnostic products. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Guangzhou Kingmed Diagnostics Group Co Ltd management
6- Mr. Yaoming LiangChairman & GM · born 1964
- Mr. Linglai WangDeputy GM, Secretary & Director · born 1972
- Ms. Ting YanDeputy GM & Director · born 1969
- Mr. Xiao Feng Ou YangDeputy GM & Director · born 1979
- Mr. Ji MaDeputy General Manager · born 1984
- Mr. Hui Yuan LiDeputy General Manager · born 1982